595 Is PHASTR faster? A target trial emulation case study in the N3C
Objectives/Goals: Our study team won a Public Health Answers to Speed Tractable Results (PHASTR) contract to conduct a target trial emulation to answer “Does metformin show a reduction of severe outcomes of COVID-19 or of Long COVID in the N3C Data Enclave?” We quickly delivered an answer due to pro...
Saved in:
| Main Authors: | Steve Johnson, Carolyn Bramante, Til Stürmer, John Buse, Talia Wiggen, Jared Huling, Andrew Toler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-04-01
|
| Series: | Journal of Clinical and Translational Science |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124011622/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study
by: Weihong Zeng, et al.
Published: (2025-05-01) -
Evaluating the therapeutic efficacy of 595 nm pulsed dye laser system for treating capillary malformations
by: Domenico Piccolo, et al.
Published: (2024-11-01) -
Faster R-CNN model for target recognition and diagnosis of scapular fractures
by: Qiong Fang, et al.
Published: (2025-04-01) -
Application of the target trial emulation framework to external comparator studies
by: Kellyn Arnold, et al.
Published: (2024-04-01) -
Small Scale Invade-Target Recognition and Location Based on Improved Faster RCNN
by: Jingyi MA, et al.
Published: (2021-03-01)